184 related articles for article (PubMed ID: 27680874)
21. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
Abermil N; Guillaud-Bataille M; Burnichon N; Venisse A; Manivet P; Guignat L; Drui D; Chupin M; Josseaume C; Affres H; Plouin PF; Bertherat J; Jeunemaître X; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2012 May; 97(5):E805-9. PubMed ID: 22419703
[TBL] [Abstract][Full Text] [Related]
22. Vulvar Melanoma in association with germline MITF p.E318K variant.
Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
[TBL] [Abstract][Full Text] [Related]
23. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
van der Tuin K; Mensenkamp AR; Tops CMJ; Corssmit EPM; Dinjens WN; van de Horst-Schrivers ANA; Jansen JC; de Jong MM; Kunst HPM; Kusters B; Leter EM; Morreau H; van Nesselrooij BMP; Oldenburg RA; Spruijt L; Hes FJ; Timmers HJLM
J Clin Endocrinol Metab; 2018 Feb; 103(2):438-445. PubMed ID: 29177515
[TBL] [Abstract][Full Text] [Related]
24. Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations.
Maffeis V; Cappellesso R; Nicolè L; Guzzardo V; Menin C; Elefanti L; Schiavi F; Guido M; Fassina A
Endocr Pathol; 2019 Dec; 30(4):276-284. PubMed ID: 31734934
[TBL] [Abstract][Full Text] [Related]
25. Cancer risks associated with the germline MITF(E318K) variant.
Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
[TBL] [Abstract][Full Text] [Related]
26. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
27. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
Castro-Vega LJ; Letouzé E; Burnichon N; Buffet A; Disderot PH; Khalifa E; Loriot C; Elarouci N; Morin A; Menara M; Lepoutre-Lussey C; Badoual C; Sibony M; Dousset B; Libé R; Zinzindohoue F; Plouin PF; Bertherat J; Amar L; de Reyniès A; Favier J; Gimenez-Roqueplo AP
Nat Commun; 2015 Jan; 6():6044. PubMed ID: 25625332
[TBL] [Abstract][Full Text] [Related]
28. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Yokoyama S; Woods SL; Boyle GM; Aoude LG; MacGregor S; Zismann V; Gartside M; Cust AE; Haq R; Harland M; Taylor JC; Duffy DL; Holohan K; Dutton-Regester K; Palmer JM; Bonazzi V; Stark MS; Symmons J; Law MH; Schmidt C; Lanagan C; O'Connor L; Holland EA; Schmid H; Maskiell JA; Jetann J; Ferguson M; Jenkins MA; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Whiteman DC; Pharoah PD; Easton DF; Dunning AM; Newton-Bishop JA; Montgomery GW; Martin NG; Mann GJ; Bishop DT; Tsao H; Trent JM; Fisher DE; Hayward NK; Brown KM
Nature; 2011 Nov; 480(7375):99-103. PubMed ID: 22080950
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
30. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
Ghiorzo P; Pastorino L; Queirolo P; Bruno W; Tibiletti MG; Nasti S; Andreotti V; ; Paillerets BB; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2013 Mar; 26(2):259-62. PubMed ID: 23167872
[TBL] [Abstract][Full Text] [Related]
32. Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma.
Wang L; Li Y; Guan X; Zhao J; Shen L; Liu J
Mol Cancer; 2018 Aug; 17(1):128. PubMed ID: 30139385
[TBL] [Abstract][Full Text] [Related]
33. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
34. A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.
Liu Q; Wang Y; Tong D; Liu G; Yuan W; Zhang J; Ye J; Zhang Y; Yuan G; Feng Q; Zhang D; Jiang J
Endocr Pathol; 2017 Mar; 28(1):75-82. PubMed ID: 28116635
[TBL] [Abstract][Full Text] [Related]
35. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
36. Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas.
Pillai S; Gopalan V; Lam AK
Crit Rev Oncol Hematol; 2017 Aug; 116():58-67. PubMed ID: 28693800
[TBL] [Abstract][Full Text] [Related]
37. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
Welander J; Söderkvist P; Gimm O
Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
39. SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling.
Blank A; Schmitt AM; Korpershoek E; van Nederveen F; Rudolph T; Weber N; Strebel RT; de Krijger R; Komminoth P; Perren A
Endocr Relat Cancer; 2010 Dec; 17(4):919-28. PubMed ID: 20702724
[TBL] [Abstract][Full Text] [Related]
40. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.
Timmers HJ; Kozupa A; Eisenhofer G; Raygada M; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2007 Mar; 92(3):779-86. PubMed ID: 17200167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
